For the Inventor, By the Inventor

Enter assignee name

Portland, OR, United States of America

Tricol Biomedical, Inc.

Calculating rank

USPTO Granted Patents = 16

EPO Patents = 3

Trademarks = 11

Forward Citations = 44

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Simon J McCarthy (16 out of 31 patents)

Sam Kuhn (9 out of 9 patents)

Barbara McGrath (8 out of 9 patents)

4. Michael Stolten (8 out of 8 patents)

5. Amanda Bennett (8 out of 8 patents)

6. Alysha Wold (5 out of 5 patents)

7. Mattie R Jones (4 out of 4 patents)

8. Jess Kimball (3 out of 4 patents)

9. Hua Xie (3 out of 8 patents)

10. Ervelyn Winata (3 out of 3 patents)

11. Cole Gannett (3 out of 3 patents)

12. Maggie Bush (1 out of 1 patent)

13. Brintha Enestvedt (1 out of 1 patent)

14. Kenneth P Perry (1 out of 1 patent)

15. Kenneth E Perry (1 out of 8 patents)

16 patents: Sort by Forward Citations

1. 12636402 - Chitosan dressing for control of gastrointestinal bleeding (2026-05-26),

2. 12616771 - Tissue adherent chitosan material that resists dissolution (2026-05-05),

3. 12508171 - Delivery systems for control of bleeding in transurethral prostatectomy (2025-12-30),

4. 12156791 - Chitosan dressing for control of bleeding in transurethral prostatectomy (2024-12-03),

5. 11890384 - Chitosan superfine fiber systems (2024-02-06),

6. 11660236 - Delivery systems for control of bleeding in transurethral prostatectomy (2023-05-30),

7. 11564673 - Delivery systems for control of gastrointestinal bleeding (2023-01-31),

8. 11234998 - Chitosan materials from carbonic acid solution (2022-02-01),

9. 11229724 - Biocompatible and bioabsorbable derivatized chitosan compositions (2022-01-25),

10. 11160901 - Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field (2021-11-02),

11. 10709817 - Biocompatible and bioabsorbable derivatized chitosan compositions (2020-07-14),

12. 10632143 - Chitosan materials from carbonic acid solution (2020-04-28),

13. 9925310 - Biocompatible and bioabsorbable derivatized chitosan compositions (2018-03-27),

14. 9925210 - Chitosan materials from carbonic acid solution (2018-03-27),

15. 9846163 - Biocompatible and bioabsorbable derivatized chitosan compositions (2017-12-19),

Company Overview

Tricol Biomedical, Inc. is a Portland-based company specializing in the development and manufacturing of innovative medical devices. The organization focuses on creating advanced solutions for healthcare, particularly in the fields of wound care and tissue regeneration. By leveraging cutting-edge technology and research, Tricol aims to enhance patient outcomes and improve the quality of care. Its commitment to innovation positions it as a key player in the biomedical sector, addressing critical needs in modern medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#62 in Portland, OR

#199 in Oregon

#19,944 in US

#37,887 in the World

Portland, OR, United States of America

Tricol Biomedical, Inc.

Forward Citations = 44

18 inventors:

Simon J McCarthy (16 out of 31 patents)

Sam Kuhn (9 out of 9 patents)

Barbara McGrath (8 out of 9 patents)

4. Michael Stolten (8 out of 8 patents)

5. Amanda Bennett (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tricol Biomedical, Inc.. Retrieved from https://idiyas.com/company/tricol-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…